ClinicalTrials.gov
public full text
Public Domain
IMUNOR® Preparation in the Prevention of COVID-19
The aim of the study is to achieve prevention of COVID-19 disease in healthcare professionals with the administration of the IMUNOR® preparation, and decreasing the symptoms should the disease appear.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Umifenovir in Hospitalized COVID-19 Patients#833447
- Intranasal INNA-051 for Prevention of COVID-19 in Adults#1213559
- Safety and Immunogenicity Evaluation of the Recombinant Flagellin Protein Adjuvant#1378572
- Efficacy, Immunogenicity and Safety of COVID-19 Vaccine , Inactivated in Children and Adolescents#123547
- ImmuneSense™ COVID-19 Study#1307222
Record · ID 1484166
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive